Literature DB >> 15261569

Binding proteins from alternative scaffolds.

Per-Ake Nygren1, Arne Skerra.   

Abstract

The use of so-called protein scaffolds for the generation of novel binding proteins via combinatorial engineering has recently emerged as a powerful alternative to natural or recombinant antibodies. This concept requires an extraordinary stable protein architecture tolerating multiple substitutions or insertions at the primary structural level. With respect to broader applicability it should involve a type of polypeptide fold which is observed in differing natural contexts and with distinct biochemical functions, so that it is likely to be adaptable to novel molecular recognition purposes. The quickly growing number of approaches can be classified into three groups: carrier proteins for the display of single variegated loops, scaffolds providing rigid elements of secondary structure, and protein frameworks supporting a group of conformationally variable loops in a fixed spatial arrangement. Generally, such artificial receptor proteins should be based on monomeric and small polypeptides that are robust, easily engineered, and efficiently produced in inexpensive prokaryotic expression systems. Today, progress in protein library technology allows for the parallel development of immunoglobulin (Ig) as well as scaffold-based affinity reagents. Both biomolecular tools have the potential to complement each other, thus expanding the possibility to find an affinity reagent suitable for a given application. The repertoire of protein scaffolds hitherto recruited for combinatorial protein engineering purposes will probably be further expanded in the future, including both additional natural proteins and de novo designed proteins, contributing to the collection of libraries available at present. In this review both the structural features and the practical use of scaffold proteins will be discussed and exemplified.

Mesh:

Substances:

Year:  2004        PMID: 15261569     DOI: 10.1016/j.jim.2004.04.006

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  35 in total

1.  Engineering of a phosphorylatable tag for specific protein binding on zirconium phosphonate based microarrays.

Authors:  Mathieu Cinier; Marc Petit; Frédéric Pecorari; Daniel R Talham; Bruno Bujoli; Charles Tellier
Journal:  J Biol Inorg Chem       Date:  2011-12-13       Impact factor: 3.358

Review 2.  A new generation of protein display scaffolds for molecular recognition.

Authors:  Ralf J Hosse; Achim Rothe; Barbara E Power
Journal:  Protein Sci       Date:  2006-01       Impact factor: 6.725

Review 3.  Engineered CH2 domains (nanoantibodies).

Authors:  Dimiter S Dimitrov
Journal:  MAbs       Date:  2009 Jan-Feb       Impact factor: 5.857

4.  Shortened engineered human antibody CH2 domains: increased stability and binding to the human neonatal Fc receptor.

Authors:  Rui Gong; Yanping Wang; Yang Feng; Qi Zhao; Dimiter S Dimitrov
Journal:  J Biol Chem       Date:  2011-06-13       Impact factor: 5.157

Review 5.  Protein scaffold-based molecular probes for cancer molecular imaging.

Authors:  Zheng Miao; Jelena Levi; Zhen Cheng
Journal:  Amino Acids       Date:  2010-02-21       Impact factor: 3.520

6.  A large human domain antibody library combining heavy and light chain CDR3 diversity.

Authors:  Weizao Chen; Zhongyu Zhu; Yang Feng; Dimiter S Dimitrov
Journal:  Mol Immunol       Date:  2009-11-01       Impact factor: 4.407

7.  In vivo targeting of HER2-positive tumor using 2-helix affibody molecules.

Authors:  Gang Ren; Jack M Webster; Zhe Liu; Rong Zhang; Zheng Miao; Hongguang Liu; Sanjiv S Gambhir; Faisal A Syud; Zhen Cheng
Journal:  Amino Acids       Date:  2011-10-08       Impact factor: 3.520

8.  64Cu-labeled affibody molecules for imaging of HER2 expressing tumors.

Authors:  Zhen Cheng; Omayra Padilla De Jesus; Daniel J Kramer; Abhijit De; Jack M Webster; Olivier Gheysens; Jelena Levi; Mohammad Namavari; Sen Wang; Jinha Mark Park; Rong Zhang; Hongguang Liu; Brian Lee; Faisal A Syud; Sanjiv Sam Gambhir
Journal:  Mol Imaging Biol       Date:  2009-09-25       Impact factor: 3.488

9.  An engineered knottin peptide labeled with 18F for PET imaging of integrin expression.

Authors:  Zheng Miao; Gang Ren; Hongguang Liu; Richard H Kimura; Lei Jiang; Jennifer R Cochran; Sanjiv Sam Gambhir; Zhen Cheng
Journal:  Bioconjug Chem       Date:  2009-12       Impact factor: 4.774

10.  Tracking molecular recognition at the atomic level with a new protein scaffold based on the OB-fold.

Authors:  John D Steemson; Matthias Baake; Jasna Rakonjac; Vickery L Arcus; Mark T Liddament
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.